Agilent Technologies, Inc. (NYSE:A) Shares Sold by Logan Capital Management Inc.

Logan Capital Management Inc. trimmed its position in Agilent Technologies, Inc. (NYSE:A) by 2.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 112,422 shares of the medical research company’s stock after selling 3,233 shares during the period. Logan Capital Management Inc.’s holdings in Agilent Technologies were worth $16,692,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Marshall Financial Group LLC purchased a new position in Agilent Technologies in the 2nd quarter valued at approximately $1,058,000. Van ECK Associates Corp boosted its stake in shares of Agilent Technologies by 6.6% during the 3rd quarter. Van ECK Associates Corp now owns 2,976,905 shares of the medical research company’s stock worth $442,011,000 after purchasing an additional 183,716 shares during the last quarter. AXA S.A. boosted its position in shares of Agilent Technologies by 32.3% in the second quarter. AXA S.A. now owns 362,945 shares of the medical research company’s stock worth $47,049,000 after acquiring an additional 88,667 shares during the last quarter. Vestal Point Capital LP acquired a new stake in shares of Agilent Technologies in the third quarter worth $14,848,000. Finally, Empowered Funds LLC boosted its position in shares of Agilent Technologies by 29.8% in the third quarter. Empowered Funds LLC now owns 30,978 shares of the medical research company’s stock worth $4,592,000 after buying an additional 7,111 shares during the period.

Insider Transactions at Agilent Technologies

In related news, SVP Dominique Grau sold 9,990 shares of the stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now owns 40,011 shares in the company, valued at approximately $5,801,595. This represents a 19.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Agilent Technologies Stock Performance

Shares of A stock traded down $2.42 during mid-day trading on Friday, reaching $138.49. The stock had a trading volume of 98,093 shares, compared to its average volume of 1,716,127. The company has a quick ratio of 1.58, a current ratio of 2.09 and a debt-to-equity ratio of 0.57. The firm’s 50 day simple moving average is $136.87 and its 200 day simple moving average is $136.60. The firm has a market cap of $39.79 billion, a PE ratio of 31.88, a P/E/G ratio of 4.48 and a beta of 1.07. Agilent Technologies, Inc. has a one year low of $124.16 and a one year high of $155.35.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.05. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The firm had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the prior year, the business earned $1.38 EPS. The business’s revenue for the quarter was up .8% compared to the same quarter last year. On average, analysts forecast that Agilent Technologies, Inc. will post 5.56 EPS for the current year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a yield of 0.72%. Agilent Technologies’s payout ratio is 21.27%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Sanford C. Bernstein lowered their price target on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a report on Tuesday, November 26th. Evercore ISI increased their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Wells Fargo & Company decreased their target price on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday. Stifel Nicolaus reiterated a “buy” rating and set a $151.00 price target on shares of Agilent Technologies in a research report on Monday, August 26th. Finally, TD Cowen upped their price objective on Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, Agilent Technologies presently has an average rating of “Hold” and a consensus target price of $143.14.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.